Unconventional chemistry to generate enabling reporting tools to be used in mono- and poly-ADP-ribosylation biology
Unconventional chemistry to generate enabling reporting tools to be used in mono- and poly-ADP-ribosylation biology
批准号:
BB/L01792X/1
负责人:
Marie Migaud
金额:
$17.85万
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2014
资助国家:
英国
项目状态:
已结题
起止时间:
2014 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Biologists working in the field of protein modifications are in need of new tools to interrogate the cellular events and mechanisms which are linked to the transfer of adenosine diphosphate (ADP) ribose units from nicotinamide adenine dinucleotide (NAD) on proteins. Through this transfer, NAD plays a pivotal role in the regulation of DNA repair, stress resistance and cell death, linking metabolism to cell survival. In mammalian cells, mono-ADP ribosylation reactions are catalysed by mono-ADP-ribosyltransferases (MART) which transfer one ADP-ribosyl unit on proteins' side chains as means of regulating the activity of the latter. Whilst having been under intense scrutiny for over a decade because of their importance in cellular homeostasis, cell division, cellular "ageing" and cancer, both the MART enzymes and their biological targets have largely remained elusive. This is mainly due to the lack of effective and specific techniques to study that biology, more particularly the limited access to specific antibodies. A key factor to identify ADP-ribosylated proteins in blot experiments and mass spectroscopy analyses is to have access to specific antibodies which can detect and report the presence of such modified proteins in functional assays. The current challenges in preparing such antibodies come from the fact that mono-ADP ribosylated peptides must remain stable to degrading enzymes for as long as the immune response is actively fighting the foreign entity and creating antibodies. To access modified proteins which look like mono-ADP ribosylated proteins but which are more stable, NAD analogues which are good substrates for MART must be synthesised. Additionally, the modifications thus introduced must be sufficiently minimal to induce the generation of antibodies which will also recognise the "true" ADP-ribosylated protein targets. This latter aspect is critical if these antibodies are to become widely used in MAR biology. The biology of polymeric ADP-ribosylation of proteins, catalysed by ADP-ribosyl polymerases (PARP) has been more readily studied due to the development of a broad range of finely-tuned biological tools, such as highly efficient antibodies and in situ detection assays. In human, five members of the PARP family are DNA binding enzymes activated by breaks to the DNA and are critical to the base excision repair process, with the sixth member (PARP13) being a newly identified mRNA binding protein. Despite extensive research leading to major drug discovery programs, poly(ADP-ribose) (PAR), as a chemical entity, has retained numerous levels of unexplored complexity which are critical to understanding its cellular properties. More specifically, the recent identification of four different poly(ADP-ribose) binding motifs have revolutionised how the decoding of this "appendage" by its partner-proteins can be explained. The limitations now reside in accessing functional and structurally defined short strands of poly-ADP-ribose that would help probe and rationalise the recognition and recruitment events elicited by the binding partners for these structurally different epitopes. Therefore, substantial progress could be achieved in the field of ADP-ribosylation if specific antibodies to MAR-ylation could be generated and stable structure-specific PAR fragments became more widely available. To access this type of tools, novel chemistry must be devised to access the required functionalities in a modular manner. We are the only synthetic laboratory that has specialised in phosphorus and nucleoside chemistry where the use of unconventional solvents and mechanochemistry allows for high synthetic efficacy in the preparation of NAD and ADP-ribose type molecules. Here, we will synthesise NAD derivatives which will be used to raise antibodies specific to protein MAR-ylation and PAR fragments with reporting properties to enable structural and functional analyses of the poly-ADP-ribolome.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1039/c5ra12239b
发表时间:
2015-01-01
期刊:
RSC ADVANCES
影响因子:
3.9
作者:
[Crossey, K., Cunningham, R. N., Migaud, M. E.]
通讯作者:
Migaud, M. E.
Enabling Phosphorus and Peptide based Chemical Biology using Ionic Liquids
-
批准号:EP/I016104/1
-
项目类别:Research Grant
-
资助金额:$25.7万
-
财政年份:2010
-
负责人:Marie Migaud
-
依托单位:
国内基金
海外基金
登录
查看更多内容
SCIENCE CHINA Chemistry
-
批准号:21224001
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:朱晓文
-
依托单位:
接枝IKVAV多肽和NGF的水凝胶对神经干细胞分化影响及其机制的研究
-
批准号:51103112
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:张平
-
依托单位:
新型二茂铁基四咪唑类大环配体的合成、表征及其金属配合物在非均相C-C偶联反应中的应用研究
-
批准号:21102132
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2011
-
负责人:张金莉
-
依托单位:
Science China Chemistry
-
批准号:21024801
-
项目类别:专项基金项目
-
资助金额:24.0万元
-
批准年份:2010
-
负责人:朱晓文
-
依托单位:
高温气化过程中煤灰矿物质演变规律的量子化学计算与实验研究
-
批准号:50906055
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2009
-
负责人:乌晓江
-
依托单位:
运用Linkage Chemistry合成新型聚合物缀合物和刷形共聚物
-
批准号:20974058
-
项目类别:面上项目
-
资助金额:12.0万元
-
批准年份:2009
-
负责人:袁金颖
-
依托单位:
基于诱导ES细胞定向分化的化合物库构建和信号转导分子事件发现
-
批准号:90813026
-
项目类别:重大研究计划
-
资助金额:60.0万元
-
批准年份:2008
-
负责人:俞永平
-
依托单位:
新型亲水作用色谱分离材料制备及其应用
-
批准号:20775079
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2007
-
负责人:徐青
-
依托单位:
合成新的树枝状共轭大分子
-
批准号:20674049
-
项目类别:面上项目
-
资助金额:27.0万元
-
批准年份:2006
-
负责人:张清
-
依托单位:
计算化学E-SCIENCE研究与示范应用
-
批准号:90612016
-
项目类别:重大研究计划
-
资助金额:160.0万元
-
批准年份:2006
-
负责人:李廉
-
依托单位: